Search

everythinglearnresearchcommunity

for

Search:↓

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

CT scans can find serious prostate cancer even when PSA levels are low.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Higher DHT in male baldness may protect against prostate cancer.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride is safe for long-term use in prostate cancer treatment.

Finasteride is effective for treating BPH but not recommended for prostate cancer prevention.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.